http://markets.ft.com/research/Markets/Tearsheets/Forecasts?s=MSB:ASX
As of Nov 18, 2013, the consensus forecast amongst 9 polled investment analysts covering Mesoblast limited advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Nov 16, 2013. The previous consensus forecast advised investors to hold their position in Mesoblast limited.
The 7 analysts offering 12 month price targets for Mesoblast limited have a median target of 7.60, with a high estimate of 14.00 and a low estimate of 3.80. The median estimate represents a 26.25% increase from the last price of 6.02.
analysts
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |